How to manage waldenstrom's macroglobulinemia in 2024.
Grunenberg A, Buske C.
Cancer Treat Rev. 2024 Apr;125:102715. doi: 10.1016/j.ctrv.2024.102715. Epub 2024 Mar 5.
MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia.
Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L, Pinkus GS, Rodig SJ, Sohani AR, Harris NL, Laramie JM, Skifter DA, Lincoln SE, Hunter ZR.
N Engl J Med. 2012 Aug 30;367(9):826-33. doi: 10.1056/NEJMoa1200710.
Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria.
Treon SP, Tedeschi A, San-Miguel J, Garcia-Sanz R, Anderson KC, Kimby E, Minnema MC, Benevolo G, Qiu L, Yi S, Terpos E, Tam CS, Castillo JJ, Morel P, Dimopoulos M, Owen RG.
Semin Hematol. 2023 Mar;60(2):97-106. doi: 10.1053/j.seminhematol.2023.03.009. Epub 2023 Apr 20.
Waldenstrom's macroglobulinemia.
Singhal N, Bapsy PP, Babu KG, Sahoo TP.
J Assoc Physicians India. 2004 Dec;52:981-5.
Waldenstrom's macroglobulinemia.
Gertz MA, Fonseca R, Rajkumar SV.
Oncologist. 2000;5(1):63-7. doi: 10.1634/theoncologist.5-1-63.
Waldenstrom's macroglobulinaemia.
[No authors listed]
Lancet. 1985 Aug 10;2(8450):311-2.
Monoclonal IgM Gammopathy and Waldenstrom's Macroglobulinemia.
Grunenberg A, Buske C.
Dtsch Arztebl Int. 2017 Nov 3;114(44):745-751. doi: 10.3238/arztebl.2017.0745.
Pathophysiology of Waldenstrom's macroglobulinemia.
Stone MJ, Pascual V.
Haematologica. 2010 Mar;95(3):359-64. doi: 10.3324/haematol.2009.017251.
Waldenstrom's macrogloblinemia/ lymphoplasmacytic lymphoma.
Treon SP, Hatjiharissi E, Merlini G.
Cancer Treat Res. 2008;142:211-42. doi: 10.1007/978-0-387-73744-7_9.
[Waldenstrom's macroglobulinemia and its individualized therapy options].
Szemlaky Z, Mikala G.
Orv Hetil. 2017 Oct;158(41):1604-1614. doi: 10.1556/650.2017.30868.
